![John Mohr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
John Mohr formerly worked at The Medicines Co., as Vice President-Medical Affairs in 2015, Tetraphase Pharmaceuticals, Inc., as Vice President-Medical Affairs from 2015 to 2016, and scPharmaceuticals, Inc., as Senior VP-Clinical Development & Medical Affairs from 2018 to 2025.
Dr. Mohr received his undergraduate degree from Texas A&M University and doctorate degree from the University of Houston.
Ehemalige bekannte Positionen von John Mohr
| Unternehmen | Position | Ende |
|---|---|---|
| SCPHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.10.2025 |
| TETRAPHASE PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2016 |
| THE MEDICINES COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2015 |
Ausbildung von John Mohr
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Houston
 University of Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
